KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 105 filers reported holding KURA ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,850,000 | +2.3% | 134,566 | +12.9% | 0.05% | +18.6% |
| Q3 2019 | $1,808,000 | -42.6% | 119,199 | -25.5% | 0.04% | -36.8% |
| Q2 2019 | $3,152,000 | +663.2% | 160,103 | +543.0% | 0.07% | +655.6% |
| Q1 2019 | $413,000 | -1.9% | 24,900 | +5.5% | 0.01% | +12.5% |
| Q2 2018 | $421,000 | -64.6% | 23,610 | -62.8% | 0.01% | -68.0% |
| Q1 2018 | $1,189,000 | +130.4% | 63,410 | +86.7% | 0.02% | +127.3% |
| Q4 2017 | $516,000 | +137.8% | 33,966 | +45.9% | 0.01% | +175.0% |
| Q2 2017 | $217,000 | – | 23,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |